Background: Ischemia-induced brain damage is the leading cause of adult disability and the fifth leading cause of death, and thus, the development of anti-apoptotic neuro-protective therapeutic agents is viewed as an attractive developmental strategy. Glycyrrhizin is the main sweet component in licorice and has a number of pharmacological activities, which include neuro-protective, anti-fungal, and anti-cariogenic activities. This study was undertaken to investigate the effects of glycyrrhizin on ischemia-induced brain damage. Materials and Methods: In infarct volumes and the levels of several apoptosis-related proteins, caspase-3, -8, 9, Bcl-xL, Bcl-2,and their activities in the brains of middle cerebral artery occlusion (MCAO) treated mice were measured using western blotting methods. Results: Single pre-treatment with glycyrrhizin (10-100 mg/kg)at 2 hours before MCAO significantly reduced infarct volumes at 24h after MCAO. In addition, glycyrrhizin effectively inhibited the activations of caspase-3 and -9 and the down-regulation of Bcl-xLprotein caused by MCAO.
Introduction
Glycyrrhizin (glycyrrhizic acid) is one of main constituents of Glycyrrhiza glabra or G. uralensis (licorice) roots, and has been shown to have a number of pharmacological activities, which including neuro-protective (Kim et al., 2011; 2012; Luo et al., 2013) , anti-fungal (Guo, 1991) , and anticariogeniceffects (Segal et al., 1985) . Isoliquiritigenin, a natural phenol isolated from licorice, has been reported to have protective effects on transient MCAO induced focal cerebral ischemia in rats (Zhan and Yang, 2006) . In total, 122 compounds have been isolated from G. uralensis and extensively tested using various bioassay methods (Ji et al., 2016; Ota et al., 2015; Yang et al., 2015b; Zhu et al., 2016) . Kumagai et al.(1957) reported glycyrrhizincompetitively inhibits the metabolism of corticosteroidsand that it has a corticosteroid-like effect (Kumagai et al., 1957) .
Corticosteroidsare often administered by clinicians, butevidence concerning their effects on acute cerebral infarction is lacking. However, corticosteroids are believed to reduce cytotoxic and vasogenic brain edema when administered to ischemic cerebral stroke (Faraji et al., 2009; Feigin et al., 2005; Sandercock and Soane, 2011) .
Stroke is a leading cause of adult death and permanent disability, and ischemic strokeaccounts for around 80% of strokes (Poisson et al., 2014) .Furthermore, the incidence of stroke is increasing among young adults (Bejot et al., 2016) .
Ischemia/reperfusion-induced stroke can be characterized by focal loss of brain blood circulation, and often leads to neuronal injury or death (Hadadha et al., 2015; Zhao et al., 2015) . Kim et al.(2012) concluded that the anti-inflammatory and anti-oxidative effects of glycyrrhizin were responsible for its neuroprotective effect post-ischemia in a rat MCAO model (Kim et al., 2012) . However, the effects of glycyrrhizinhave not been determined in a mouse MCAO model of ischemia. Thus, in the present study, we sought to determine whether glycyrrhizinprotects against ischemia/reperfusion induced brain damage and to identify the mechanism responsible in a mouse MCAO model.
Materials and Methods

Glycyrrhizin treatment
Glycyrrhizin was purchased from Sigma-Aldrich (Millipore Sigma, MO, USA), dissolved in dimethyl sulfoxide (DMSO) to concentration of 100 mg/ml, and then again diluted with tap water to concentration of 2 mg/ml.
Animal model
The animal experiment protocol was approved by the ethics committee of our institution (approval number, PNU-2016-1087). Male SPF C57BL/6 mice (DaehanBiolink, Chungbuk, Korea) (22-25 g) were housed in a humidity and temperature controlled environment under a 12h light cycle, and provided food and water ad libitum. For the experiment animals were randomly divided into five groups, namely, the sham control group (members of which underwent surgery but not MCAO), the non-glycyrrhizin treated MCAO group (the MCAO control group), and the 10, 30, or 100 mg/kg glycyrrhizin treated groups (the 10, 30, and 100 mg/kg groups)each group consisted of at least 15animals.
Before MCAO, mice in glycyrrhizin treatment groups were orally administered 10, 30, or 100 mg/kg of body weight 1 hr before commencing the MCAO procedure ( Fig. 1(A) ). MCAO was conducted under 2% isoflurane anesthesia. During surgery, rectal temperature was maintained at 37±0.5°C with a heating pad, andrelative cerebral blood flow (rCBF) was monitored using a laser Doppler blood flow system (moorVMS-LDF, Moor Instruments, Devon, UK). Briefly, under a stereo microscope (Nikon745, Tokyo), the left external carotid artery and the left common carotid artery were bound with 4/0 silk sutures (Ethicon Inc., NJ, USA).Theleft middle cerebral artery was then occluded using a filament (11 mm length of 8/0 nylon suture with a silicon-coated tip), and after 2h of occlusion, the filament was withdrawn. The success of the procedure was confirmed by a reduction in rCBF of >80% during the 2h ischemic period, and a sharp increase in rCBF to >90% of baseline during reperfusion. Surgical procedures performed in an identical manner in the sham group but the left middle cerebral artery was not occluded.Mice were anesthetized and sacrificed24 hrafter commencing MCAO. 
Measurement of infarct volumes
Brains harvested at 24h post-MCAO were immediately sectioned at 1 mm coronal sections to obtain 10 sections/brain. Sections were then incubated with 2% 2,3,5-triphenyl-tetrazolium chloride (TTC) solution for 17 min at 25°C and fixed in 10% neutral buffered formalin for more than 2 hr. Digital images were obtained using a digital camera, and infarct and relative edema volumes were calculated using Image J software (NIH, Maryland, USA).
Neurological deficit scores
Neurological deficit scores were assessed at 24 hrpost-MCAOusing a five-point scale. Briefly, the scores were calculated as follows: 0, no neurological deficit; 1, failure to extend right forepawand a reduced grip; 2, spontaneous movement in all directions and circling to the rightwhen the tail was pulled; 3, circling or walking to the rightwhen stimulated; 4, unresponsive to stimulation or stroke-related death.
Western blot analysis
Ipsi-lateral brain tissues including hippocampus and cortex were extracted and homogenized in tissue lysis buffer. Proteins were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and then transferred to nitrocellulose membranes (Whatman, Maidstone, UK).Membranes were blocked using 5% skim milk in TBST buffer for 1 hr at room temperature and then incubated overnight at 4°C with specific antibodies for caspase-3, -8, 9, Bcl-xL, Bcl-2 (1:1000), and β-actin (1:2000) for internal control. Antibodies listed above were purchased from Cell Signaling Technology (Danvers, MA, USA). After overnight incubation, horse radish peroxidase (HRP) conjugated goat anti-rabbit IgG, pAb (1:5000) and HRP conjugated goat anti-mouse IgG pAb (1:3000) were added for 2 hours. Membranes were then treated with ECL solution (GenDEPOT, Houston, TX, USA) and protein bands were detected using a photosensitive luminescent analyzer system (Amersham ™ Imager 600, UK). Relative protein amounts were analyzedusing the Image J program (NIH, Maryland, USA) versus β-actin.
Statistical analysis
One-way ANOVA was used to determine the statistical significance of differences. Data are expressed as means±standard deviations (means ±SD). SIGMAPLOT 12.0 version was used to statistical analysis, and p-values of ≤0.05 were considered statistically significant.
Results
Effects of glycyrrhizin on behavioral deficits and infarct volumes
At 24h post-MCAO, motor behavioral deficit scores were significantly higher in mice subjected to MCAO.Glycyrrhizin pre-treatment exhibited no significant reduction in neuronal deficit scores versus the MCAO control group (Figure 2(A) ). Regions of ischemic infarction were confirmed by TTC staining, and MCAO was found to induce severe damage in ipsilateral hemispheres. However, mice pre-treated with glycyrrhizin (10, 30, or 100 mg/kg) had significantly smaller infarct lesions than MCAO controls (Figure 2(B) ). 
Effects of glycyrrhizin on the expressions of apoptosis related proteins
In ipsilateral hemispheres of MCAO subjected brains, western blot analysis at 24-post MCAO revealed Bcl-xLlevels were significantly lower than in sham controls (Figure 3) . However, mice in the 10, 30, and 100 mg/kg groups hadsignificant higher Bcl-xLlevels than mice in the sham control group (Figure 3) . Glycyrrhizin pre-treatment down-regulated caspase-3 and caspase-9 in ischemic brains, but caspase-8 levels were similar in all five study groups (Figure 4) .
Western blot analysis at 24h-post MCAO revealed Bcl-2 expression was significantly lower in all MCAO groups than in sham controls ( Figure 5 ). 
Discussion and Conclusion
Ischemia-induced brain damage, also called "stroke" or "brain attack", is associated with oxidative stress and neuro-inflammation,in turn, cause diverse motor and speechdisorders (Chamorro et al., 2016; Roth andLiesz, 2016) . A stroke can occur at any time, and in the USA, nearly 800,000 people experience a new or recurrent stroke annually.Stroke is the leading cause of adult disability and the fifth-most leading cause of death(Bejotet al., 2016; Hachinski andAzarpazhooh, 2016; Poisson et al., 2014) . The severities of motor and speech disordersdepend on the extent of brain damage (Barlow, 2016) , and thus, anti-apoptotic neuroprotective therapeutic agents offer an attractive developmental strategy.
In a preliminary study, we observed oral glycyrrhizin reducedbrain infarct volumes in MCAOtreated mice, and in the present study, single doses of glycyrrhizinof from 10 to 100 mg/kg produced similar results (Figures 1 and 2) . In order to identify beneficial effects of glycyrrhizin, we assessed the levels of several apoptosis-related proteins and their activities in ipsilateral brains.
Caspases are classified based on the roles they play during apoptosis.Caspases-8 and -9 are called "initiator caspases", because they activate executioner caspases (caspases -3, -6, and -7), which induce the destruction ofkey structural proteins. Caspase-3 is responsible for DNA fragmentation and plays a critical role in apoptosis (McIlwain et al., 2015; Sun et al., 2015) . Recently, several researchers have suggested ischemia/reperfusion-induced brain injury might be ameliorated by inhibiting caspase-3 signaling (Wen et al., 2016; Yang et al., 2015a) , and in the present study, glycyrrhizinwas found to inhibit increase in caspase-3 and -9 levelscaused by MCAO-induced brain damage (Figure 4) .
The Bcl-2 and caspase families play act as regulators of the apoptotic pathway, and interestingly, members of this family act as positive or negative regulators. Bcl-xL is an anti-apoptotic member of the Bcl-2 family (Dragovich et al., 1998; Wu and Tang, 2016) , and in the present study, its levels, and those of Bcl-2, were significantly lower in damaged brains.Furthermore, glycyrrhizinpretreatment effectively inhibited reduced this MCAO-induced Bcl-xLdown-regulation (Figure 3, Figure 5 ).
Our results suggest that glycyrrhizinpretreatment decreasedinfarct volumesin the brains of MCAOtreated miceby regulating apoptosis-related protein signaling ( Figure 6 ). Accordingly, our findings indicate that glycyrrhizinis a promising candidate for the prevention or treatment of ischemia-induced brain damage. 
